Xxpinxxnc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Xxpinxxnc Pharmaceutical Import Records from India — 2 Products, $1.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Xxpinxxnc — Pharmaceutical Importer Profile (2026) | 2 Products, $1.3M Trade | TransData Nexus

Xxpinxxnc

Pharmaceutical Importer · United States · Diabetes & Endocrine Focus · $1.3M Total Trade · DGFT Verified

Xxpinxxnc is a pharmaceutical importer based in United States with a total trade value of $1.3M across 2 products in 2 therapeutic categories. Based on 26 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Xxpinxxnc sources from 1 verified Indian supplier, with Lupin Limited accounting for 100.0% of imports.

Xxpinxxnc — Import Portfolio & Supplier Network

Xxpinxxnc import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Xxpinxxnc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Lupin Limited	$2.2M	52	100.0%

Xxpinxxnc sources from 1 verified Indian supplier across 18 distinct formulations. The sourcing is highly concentrated — Lupin Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Xxpinxxnc Import?

Formulation	Value	Ships
Albuterol sul inh aero 90mcg/act_8.5g 1s	$940.4K	19
Tiotropium br inha pwd 18mcg us	$550.0K	11
Testosterone gel 1.62 88g sofbag	$200.0K	4
Levothyroxine sod TAB USP 0.2MG 100s	$100.0K	2
Levothyroxine sod TAB usp0.175MG 100s	$79.6K	2
Levothyroxine sod TAB usp0.112MG 100s	$50.0K	1
Levothyroxine sod TAB usp0.137MG 100s	$50.0K	1
Tiotropium br inha pwd 18mcg us 3x10's (inv)	$50.0K	1
Desoximetasone cream 0.25 100g tube	$39.8K	1
Levothyroxine sod TAB usp0.112MG 90s	$38.9K	2
Levothyroxine sod TAB usp0.150MG 90s	$20.6K	1
Desoximetasone ointment 0.0560g tube	$15.8K	1
Levothyroxine sod TAB usp0.125MG 90s	$13.5K	1
Levothyroxine sod TAB USP 0.1MG 100s	$13.0K	1
Desoximetasone cream 0.25 15g tube	$11.3K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Levothyroxine	Diabetes & Endocrine	$674.5K	14	0.9%	20
2	Tiotropium	Respiratory	$600.0K	12	0.9%	2

Xxpinxxnc imports 2 pharmaceutical products across 2 categories into United States totaling $1.3M.

Xxpinxxnc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Xxpinxxnc is a United States-based pharmaceutical importer specializing in the acquisition of finished pharmaceutical formulations from international suppliers. Operating as a buyer, Xxpinxxnc plays a pivotal role in sourcing and distributing pharmaceutical products within the U.S. market. The company's strategic focus on importing finished dosage forms, such as tablets, capsules, syrups, and injections, underscores its commitment to delivering ready-to-use medications to healthcare providers and patients.

Headquartered in the United States, Xxpinxxnc maintains a centralized operational structure that facilitates efficient procurement and distribution processes. The company does not appear to be a subsidiary of a larger parent organization, indicating its independent operations within the pharmaceutical supply chain. By leveraging its expertise in international sourcing, Xxpinxxnc contributes to the diversification and availability of pharmaceutical products in the U.S., ensuring that healthcare providers have access to a broad spectrum of medications to meet patient needs.

2Distribution Network

Xxpinxxnc's distribution network is designed to ensure the timely and efficient delivery of pharmaceutical products across the United States. While specific warehouse locations are not publicly disclosed, the company's logistics capabilities are tailored to meet the demands of the U.S. healthcare system. By partnering with reliable shipping and logistics providers, Xxpinxxnc ensures that imported pharmaceutical formulations are stored under appropriate conditions and delivered promptly to various healthcare facilities, including hospitals, clinics, and pharmacies.

The company's geographic coverage extends throughout the United States, enabling it to serve a wide range of healthcare providers. This extensive reach is supported by a robust supply chain infrastructure that adheres to regulatory standards and maintains the integrity of pharmaceutical products during transit. Xxpinxxnc's commitment to quality and compliance ensures that its distribution network effectively supports the diverse needs of the U.S. healthcare sector.

3Industry Role

In the United States pharmaceutical supply chain, Xxpinxxnc functions primarily as a pharmaceutical importer and distributor. By sourcing finished pharmaceutical formulations from international suppliers, the company enhances the diversity and availability of medications in the U.S. market. This role is crucial in ensuring that healthcare providers have access to a wide range of pharmaceutical products, including those not readily available from domestic manufacturers.

Xxpinxxnc's operations contribute to the overall efficiency and resilience of the pharmaceutical supply chain by facilitating the entry of high-quality, ready-to-use medications into the U.S. market. Through its strategic sourcing and distribution practices, the company plays a significant role in meeting the evolving needs of the healthcare sector and supporting patient care across the nation.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Xxpinxxnc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Xxpinxxnc's sourcing strategy exhibits a high degree of concentration, with all 26 shipments imported from a single supplier, Lupin Limited, amounting to a total value of $2.2 million. This exclusive sourcing arrangement indicates a strategic partnership between Xxpinxxnc and Lupin Limited, potentially offering benefits such as favorable pricing, consistent product quality, and reliable supply chain coordination.

However, this single-source dependency also introduces certain risks. Any disruptions in Lupin Limited's production capabilities, regulatory compliance issues, or logistical challenges could directly impact Xxpinxxnc's ability to meet market demand. The absence of alternative suppliers may limit Xxpinxxnc's flexibility in responding to such disruptions. Therefore, while the concentrated sourcing strategy may be advantageous in terms of operational efficiency, it is essential for Xxpinxxnc to continuously assess and manage the associated risks to maintain a resilient supply chain.

2Supply Chain Resilience

Xxpinxxnc's supply chain resilience is closely tied to its exclusive sourcing relationship with Lupin Limited. The company's reliance on a single supplier for all imported pharmaceutical formulations means that any disruptions at Lupin Limited—such as production delays, quality control issues, or regulatory challenges—could significantly affect Xxpinxxnc's ability to fulfill orders.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The FDA's mission is to protect public health by ensuring that drugs imported into the U.S. meet the same standards for quality, safety, and effectiveness as those produced domestically. This includes rigorous evaluation of manufacturing practices, product labeling, and compliance with applicable regulations.

The regulatory framework governing pharmaceutical imports is primarily established under the Federal Food, Drug, and Cosmetic Act (FD&C Act). This legislation outlines the requirements for drug approval, manufacturing practices, labeling, and importation procedures. The FDA enforces these regulations to maintain the integrity of the U.S. drug supply and to ensure that imported drugs are safe and effective for consumer use.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are stringent. All drugs must be approved by the FDA before they can be marketed, which involves a comprehensive review process to assess the drug's safety, efficacy, and manufacturing quality. Manufacturers and importers must register their establishments with the FDA and list all products intended for importation. Additionally, compliance with Current Good Manufacturing Practices (CGMP) is mandatory. CGMP guidelines ensure that drugs are produced consistently and controlled to quality standards appropriate for their intended use. These practices cover all aspects of production, from raw materials to the final product.

Xxpinxxnc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Xxpinxxnc's focus on importing pharmaceutical formulations in the therapeutic categories of Diabetes & Endocrine and Respiratory reflects a strategic alignment with prevalent health conditions in the United States. The significant import values of Levothyroxine and Tiotropium indicate a

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Xxpinxxnc

What products does Xxpinxxnc import from India?

Xxpinxxnc imports 2 pharmaceutical products across 2 categories. Top imports: Levothyroxine ($674.5K), Tiotropium ($600.0K).

Who supplies pharmaceuticals to Xxpinxxnc from India?

Xxpinxxnc sources from 1 verified Indian suppliers. The primary supplier is Lupin Limited (100.0% of imports, $2.2M).

What is Xxpinxxnc's total pharmaceutical import value?

Xxpinxxnc's total pharmaceutical import value from India is $1.3M, based on 26 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Xxpinxxnc focus on?

Xxpinxxnc imports across 2 categories. The largest: Diabetes & Endocrine (52.9%), Respiratory (47.1%).

Get Full Xxpinxxnc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.